Global Complement Drug Market Growth (Status and Outlook) 2022-2028
The global market for Complement Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Complement Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Complement Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Complement Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Complement Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Complement Drug players cover Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche and Apellis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Complement Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Complement Drug market, with both quantitative and qualitative data, to help readers understand how the Complement Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Complement Drug market and forecasts the market size by Type (Peptides, Antibodies and Others), by Application (Blood Disease, Kidney Disease and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Peptides
Antibodies
Others
Segmentation by application
Blood Disease
Kidney Disease
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novartis AG
Alexion Pharmaceuticals
ChemoCentryx
Roche
Apellis
Regeneron
Amgen
Alnylam
UCB
InflaRx
ChemoCentryx
Innate Pharma
Ionis Pharmaceuticals
Avant Immunotherapeutics
Pfizer
Sanofi
Omeros
GenMab
Akari Therapeutics
AbbVie
Chapter Introduction
Chapter 1: Scope of Complement Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Complement Drug market size and CAGR, Complement Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Complement Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Complement Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Complement Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam and UCB, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Complement Drug Market Size 2017-2028
2.1.2 Complement Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Complement Drug Segment by Type
2.2.1 Peptides
2.2.2 Antibodies
2.2.3 Others
2.3 Complement Drug Market Size by Type
2.3.1 Complement Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Complement Drug Market Size Market Share by Type (2017-2022)
2.4 Complement Drug Segment by Application
2.4.1 Blood Disease
2.4.2 Kidney Disease
2.4.3 Others
2.5 Complement Drug Market Size by Application
2.5.1 Complement Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Complement Drug Market Size Market Share by Application (2017-2022)
3 Complement Drug Market Size by Player
3.1 Complement Drug Market Size Market Share by Players
3.1.1 Global Complement Drug Revenue by Players (2020-2022)
3.1.2 Global Complement Drug Revenue Market Share by Players (2020-2022)
3.2 Global Complement Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Complement Drug by Regions
4.1 Complement Drug Market Size by Regions (2017-2022)
4.2 Americas Complement Drug Market Size Growth (2017-2022)
4.3 APAC Complement Drug Market Size Growth (2017-2022)
4.4 Europe Complement Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Complement Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Complement Drug Market Size by Country (2017-2022)
5.2 Americas Complement Drug Market Size by Type (2017-2022)
5.3 Americas Complement Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Complement Drug Market Size by Region (2017-2022)
6.2 APAC Complement Drug Market Size by Type (2017-2022)
6.3 APAC Complement Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Complement Drug by Country (2017-2022)
7.2 Europe Complement Drug Market Size by Type (2017-2022)
7.3 Europe Complement Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Complement Drug by Region (2017-2022)
8.2 Middle East & Africa Complement Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Complement Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Complement Drug Market Forecast
10.1 Global Complement Drug Forecast by Regions (2023-2028)
10.1.1 Global Complement Drug Forecast by Regions (2023-2028)
10.1.2 Americas Complement Drug Forecast
10.1.3 APAC Complement Drug Forecast
10.1.4 Europe Complement Drug Forecast
10.1.5 Middle East & Africa Complement Drug Forecast
10.2 Americas Complement Drug Forecast by Country (2023-2028)
10.2.1 United States Complement Drug Market Forecast
10.2.2 Canada Complement Drug Market Forecast
10.2.3 Mexico Complement Drug Market Forecast
10.2.4 Brazil Complement Drug Market Forecast
10.3 APAC Complement Drug Forecast by Region (2023-2028)
10.3.1 China Complement Drug Market Forecast
10.3.2 Japan Complement Drug Market Forecast
10.3.3 Korea Complement Drug Market Forecast
10.3.4 Southeast Asia Complement Drug Market Forecast
10.3.5 India Complement Drug Market Forecast
10.3.6 Australia Complement Drug Market Forecast
10.4 Europe Complement Drug Forecast by Country (2023-2028)
10.4.1 Germany Complement Drug Market Forecast
10.4.2 France Complement Drug Market Forecast
10.4.3 UK Complement Drug Market Forecast
10.4.4 Italy Complement Drug Market Forecast
10.4.5 Russia Complement Drug Market Forecast
10.5 Middle East & Africa Complement Drug Forecast by Region (2023-2028)
10.5.1 Egypt Complement Drug Market Forecast
10.5.2 South Africa Complement Drug Market Forecast
10.5.3 Israel Complement Drug Market Forecast
10.5.4 Turkey Complement Drug Market Forecast
10.5.5 GCC Countries Complement Drug Market Forecast
10.6 Global Complement Drug Forecast by Type (2023-2028)
10.7 Global Complement Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Complement Drug Product Offered
11.1.3 Novartis AG Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Information
11.2.2 Alexion Pharmaceuticals Complement Drug Product Offered
11.2.3 Alexion Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Alexion Pharmaceuticals Main Business Overview
11.2.5 Alexion Pharmaceuticals Latest Developments
11.3 ChemoCentryx
11.3.1 ChemoCentryx Company Information
11.3.2 ChemoCentryx Complement Drug Product Offered
11.3.3 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 ChemoCentryx Main Business Overview
11.3.5 ChemoCentryx Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Complement Drug Product Offered
11.4.3 Roche Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Apellis
11.5.1 Apellis Company Information
11.5.2 Apellis Complement Drug Product Offered
11.5.3 Apellis Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Apellis Main Business Overview
11.5.5 Apellis Latest Developments
11.6 Regeneron
11.6.1 Regeneron Company Information
11.6.2 Regeneron Complement Drug Product Offered
11.6.3 Regeneron Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Regeneron Main Business Overview
11.6.5 Regeneron Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Complement Drug Product Offered
11.7.3 Amgen Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Alnylam
11.8.1 Alnylam Company Information
11.8.2 Alnylam Complement Drug Product Offered
11.8.3 Alnylam Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Alnylam Main Business Overview
11.8.5 Alnylam Latest Developments
11.9 UCB
11.9.1 UCB Company Information
11.9.2 UCB Complement Drug Product Offered
11.9.3 UCB Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 UCB Main Business Overview
11.9.5 UCB Latest Developments
11.10 InflaRx
11.10.1 InflaRx Company Information
11.10.2 InflaRx Complement Drug Product Offered
11.10.3 InflaRx Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 InflaRx Main Business Overview
11.10.5 InflaRx Latest Developments
11.11 ChemoCentryx
11.11.1 ChemoCentryx Company Information
11.11.2 ChemoCentryx Complement Drug Product Offered
11.11.3 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 ChemoCentryx Main Business Overview
11.11.5 ChemoCentryx Latest Developments
11.12 Innate Pharma
11.12.1 Innate Pharma Company Information
11.12.2 Innate Pharma Complement Drug Product Offered
11.12.3 Innate Pharma Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Innate Pharma Main Business Overview
11.12.5 Innate Pharma Latest Developments
11.13 Ionis Pharmaceuticals
11.13.1 Ionis Pharmaceuticals Company Information
11.13.2 Ionis Pharmaceuticals Complement Drug Product Offered
11.13.3 Ionis Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Ionis Pharmaceuticals Main Business Overview
11.13.5 Ionis Pharmaceuticals Latest Developments
11.14 Avant Immunotherapeutics
11.14.1 Avant Immunotherapeutics Company Information
11.14.2 Avant Immunotherapeutics Complement Drug Product Offered
11.14.3 Avant Immunotherapeutics Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Avant Immunotherapeutics Main Business Overview
11.14.5 Avant Immunotherapeutics Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Complement Drug Product Offered
11.15.3 Pfizer Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 Sanofi
11.16.1 Sanofi Company Information
11.16.2 Sanofi Complement Drug Product Offered
11.16.3 Sanofi Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Sanofi Main Business Overview
11.16.5 Sanofi Latest Developments
11.17 Omeros
11.17.1 Omeros Company Information
11.17.2 Omeros Complement Drug Product Offered
11.17.3 Omeros Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Omeros Main Business Overview
11.17.5 Omeros Latest Developments
11.18 GenMab
11.18.1 GenMab Company Information
11.18.2 GenMab Complement Drug Product Offered
11.18.3 GenMab Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 GenMab Main Business Overview
11.18.5 GenMab Latest Developments
11.19 Akari Therapeutics
11.19.1 Akari Therapeutics Company Information
11.19.2 Akari Therapeutics Complement Drug Product Offered
11.19.3 Akari Therapeutics Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Akari Therapeutics Main Business Overview
11.19.5 Akari Therapeutics Latest Developments
11.20 AbbVie
11.20.1 AbbVie Company Information
11.20.2 AbbVie Complement Drug Product Offered
11.20.3 AbbVie Complement Drug Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 AbbVie Main Business Overview
11.20.5 AbbVie Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Complement Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Peptides
Table 3. Major Players of Antibodies
Table 4. Major Players of Others
Table 5. Complement Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Complement Drug Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Complement Drug Market Size Market Share by Type (2017-2022)
Table 8. Complement Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Complement Drug Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Complement Drug Market Size Market Share by Application (2017-2022)
Table 11. Global Complement Drug Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Complement Drug Revenue Market Share by Player (2020-2022)
Table 13. Complement Drug Key Players Head office and Products Offered
Table 14. Complement Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Complement Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Complement Drug Market Size Market Share by Regions (2017-2022)
Table 19. Americas Complement Drug Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Complement Drug Market Size Market Share by Country (2017-2022)
Table 21. Americas Complement Drug Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Complement Drug Market Size Market Share by Type (2017-2022)
Table 23. Americas Complement Drug Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Complement Drug Market Size Market Share by Application (2017-2022)
Table 25. APAC Complement Drug Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Complement Drug Market Size Market Share by Region (2017-2022)
Table 27. APAC Complement Drug Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Complement Drug Market Size Market Share by Type (2017-2022)
Table 29. APAC Complement Drug Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Complement Drug Market Size Market Share by Application (2017-2022)
Table 31. Europe Complement Drug Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Complement Drug Market Size Market Share by Country (2017-2022)
Table 33. Europe Complement Drug Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Complement Drug Market Size Market Share by Type (2017-2022)
Table 35. Europe Complement Drug Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Complement Drug Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Complement Drug Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Complement Drug Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Complement Drug Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Complement Drug Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Complement Drug Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Complement Drug Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Complement Drug
Table 44. Key Market Challenges & Risks of Complement Drug
Table 45. Key Industry Trends of Complement Drug
Table 46. Global Complement Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Complement Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Complement Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Complement Drug Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Complement Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Complement Drug Market Size Market Share Forecast by Application (2023-2028)
Table 52. Novartis AG Details, Company Type, Complement Drug Area Served and Its Competitors
Table 53. Novartis AG Complement Drug Product Offered
Table 54. Novartis AG Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Novartis AG Main Business
Table 56. Novartis AG Latest Developments
Table 57. Alexion Pharmaceuticals Details, Company Type, Complement Drug Area Served and Its Competitors
Table 58. Alexion Pharmaceuticals Complement Drug Product Offered
Table 59. Alexion Pharmaceuticals Main Business
Table 60. Alexion Pharmaceuticals Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Alexion Pharmaceuticals Latest Developments
Table 62. ChemoCentryx Details, Company Type, Complement Drug Area Served and Its Competitors
Table 63. ChemoCentryx Complement Drug Product Offered
Table 64. ChemoCentryx Main Business
Table 65. ChemoCentryx Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. ChemoCentryx Latest Developments
Table 67. Roche Details, Company Type, Complement Drug Area Served and Its Competitors
Table 68. Roche Complement Drug Product Offered
Table 69. Roche Main Business
Table 70. Roche Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Roche Latest Developments
Table 72. Apellis Details, Company Type, Complement Drug Area Served and Its Competitors
Table 73. Apellis Complement Drug Product Offered
Table 74. Apellis Main Business
Table 75. Apellis Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Apellis Latest Developments
Table 77. Regeneron Details, Company Type, Complement Drug Area Served and Its Competitors
Table 78. Regeneron Complement Drug Product Offered
Table 79. Regeneron Main Business
Table 80. Regeneron Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Regeneron Latest Developments
Table 82. Amgen Details, Company Type, Complement Drug Area Served and Its Competitors
Table 83. Amgen Complement Drug Product Offered
Table 84. Amgen Main Business
Table 85. Amgen Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Amgen Latest Developments
Table 87. Alnylam Details, Company Type, Complement Drug Area Served and Its Competitors
Table 88. Alnylam Complement Drug Product Offered
Table 89. Alnylam Main Business
Table 90. Alnylam Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Alnylam Latest Developments
Table 92. UCB Details, Company Type, Complement Drug Area Served and Its Competitors
Table 93. UCB Complement Drug Product Offered
Table 94. UCB Main Business
Table 95. UCB Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. UCB Latest Developments
Table 97. InflaRx Details, Company Type, Complement Drug Area Served and Its Competitors
Table 98. InflaRx Complement Drug Product Offered
Table 99. InflaRx Main Business
Table 100. InflaRx Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. InflaRx Latest Developments
Table 102. ChemoCentryx Details, Company Type, Complement Drug Area Served and Its Competitors
Table 103. ChemoCentryx Complement Drug Product Offered
Table 104. ChemoCentryx Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. ChemoCentryx Main Business
Table 106. ChemoCentryx Latest Developments
Table 107. Innate Pharma Details, Company Type, Complement Drug Area Served and Its Competitors
Table 108. Innate Pharma Complement Drug Product Offered
Table 109. Innate Pharma Main Business
Table 110. Innate Pharma Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Innate Pharma Latest Developments
Table 112. Ionis Pharmaceuticals Details, Company Type, Complement Drug Area Served and Its Competitors
Table 113. Ionis Pharmaceuticals Complement Drug Product Offered
Table 114. Ionis Pharmaceuticals Main Business
Table 115. Ionis Pharmaceuticals Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Ionis Pharmaceuticals Latest Developments
Table 117. Avant Immunotherapeutics Details, Company Type, Complement Drug Area Served and Its Competitors
Table 118. Avant Immunotherapeutics Complement Drug Product Offered
Table 119. Avant Immunotherapeutics Main Business
Table 120. Avant Immunotherapeutics Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Avant Immunotherapeutics Latest Developments
Table 122. Pfizer Details, Company Type, Complement Drug Area Served and Its Competitors
Table 123. Pfizer Complement Drug Product Offered
Table 124. Pfizer Main Business
Table 125. Pfizer Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Pfizer Latest Developments
Table 127. Sanofi Details, Company Type, Complement Drug Area Served and Its Competitors
Table 128. Sanofi Complement Drug Product Offered
Table 129. Sanofi Main Business
Table 130. Sanofi Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Sanofi Latest Developments
Table 132. Omeros Details, Company Type, Complement Drug Area Served and Its Competitors
Table 133. Omeros Complement Drug Product Offered
Table 134. Omeros Main Business
Table 135. Omeros Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Omeros Latest Developments
Table 137. GenMab Details, Company Type, Complement Drug Area Served and Its Competitors
Table 138. GenMab Complement Drug Product Offered
Table 139. GenMab Main Business
Table 140. GenMab Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. GenMab Latest Developments
Table 142. Akari Therapeutics Details, Company Type, Complement Drug Area Served and Its Competitors
Table 143. Akari Therapeutics Complement Drug Product Offered
Table 144. Akari Therapeutics Main Business
Table 145. Akari Therapeutics Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. Akari Therapeutics Latest Developments
Table 147. AbbVie Details, Company Type, Complement Drug Area Served and Its Competitors
Table 148. AbbVie Complement Drug Product Offered
Table 149. AbbVie Main Business
Table 150. AbbVie Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. AbbVie Latest Developments
List of Figures
List of Figures
Figure 1. Complement Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Complement Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Complement Drug Market Size Market Share by Type in 2021
Figure 7. Complement Drug in Blood Disease
Figure 8. Global Complement Drug Market: Blood Disease (2017-2022) & ($ Millions)
Figure 9. Complement Drug in Kidney Disease
Figure 10. Global Complement Drug Market: Kidney Disease (2017-2022) & ($ Millions)
Figure 11. Complement Drug in Others
Figure 12. Global Complement Drug Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Complement Drug Market Size Market Share by Application in 2021
Figure 14. Global Complement Drug Revenue Market Share by Player in 2021
Figure 15. Global Complement Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Complement Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Complement Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Complement Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Complement Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Complement Drug Value Market Share by Country in 2021
Figure 21. Americas Complement Drug Consumption Market Share by Type in 2021
Figure 22. Americas Complement Drug Market Size Market Share by Application in 2021
Figure 23. United States Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Complement Drug Market Size Market Share by Region in 2021
Figure 28. APAC Complement Drug Market Size Market Share by Application in 2021
Figure 29. China Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Complement Drug Market Size Market Share by Country in 2021
Figure 36. Europe Complement Drug Market Size Market Share by Type in 2021
Figure 37. Europe Complement Drug Market Size Market Share by Application in 2021
Figure 38. Germany Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Complement Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Complement Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Complement Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Complement Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Complement Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Complement Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Complement Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Complement Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Complement Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Complement Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Complement Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Complement Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Complement Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Complement Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Complement Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Complement Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Complement Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Complement Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Complement Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Complement Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Complement Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Complement Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Complement Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Complement Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Complement Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Complement Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Complement Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Complement Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Complement Drug Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets